-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Machine learning algorithms can help predict positive resection margin and lymph node metastases among patients with pancreatic ductal adenocarcinoma, according to study results.The approach yielded greater positive predictive values than CT scan for both variables, findings presented at Society of Surgical Oncology Annual Meeting showed.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
A long course of chemoradiation therapy appeared associated with higher organ preservation rates vs. a short course among a cohort of patients with rectal cancer, according to a study presented at ASCO Gastrointestinal Cancers Symposium.Planned ongoing research into the total neoadjuvant therapy strategies should definitively confirm the findings, researchers concluded.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Annals of Surgical Oncology –
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Neoadjuvant immunotherapy effective regardless of race in triple-negative breast cancer - 2 year(s) ago
Results of a phase 1/phase 2 study showed similar treatment outcomes among Black and non-Black women who received durvalumab plus chemotherapy prior to surgery for triple-negative breast cancer.Data published in Clinical Cancer Research revealed no statistically significant differences in efficacy outcomes according to race and no additional treatment-related adverse events.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Background The impact of neoadjuvant therapy (NAT) on pathological outcomes, including microscopic venous invasion (MVI), remains unclear in pancreatic cancer. Methods A total of 456 patients who underwent pancreatectomy for resectable and borderline resectable pancreatic cancer between July 2012 and February 2020 were retrospectively reviewed. Patients were divided into two groups: patients with…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
“We definitely don’t have a clear standard,” says Shawn Dason, MD, FRCSC.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
#VisualAbstract : MRI Assessment of Extramural Venous Invasion Before and After Total #NeoadjuvantTherapy for Locally Advanced #RectalCancer and Its Association with Disease-Free and Overall Survival @hannahmarieT87 @MSKCancerCenter https://t.co/Gv7HO5O8ko https://t.co/LIFHCpsAnv